[ASAP] Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00923

Source: Molecular Pharmaceutics - December 23, 2022 Category: Drugs & Pharmacology Authors: Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won-Kyu Lee, Youn-Jae Kim, and Sang Taek Jung Source Type: research